Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Fernando Laso-García
Hospital Universitario La Paz - Department of Neurology and Stroke Center
Madrid
Spain
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
182
TOTAL CITATIONS
3
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Short-Term Safety of Allogeneic Adipose-Tissue Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A Phase II, Randomised, Double-Blind, Placebo-Controlled, Single-Centre, Pilot Clinical Trial
Number of pages: 107
Posted: 19 Jul 2019
Blanca Fuentes
,
Raquel Gutiérrez-Zúñiga
,
María Gutiérrez-Fernández
,
María Alonso de Leciñana
,
Alberto M. Borobia
,
José C. Martínez-Ávila
,
Gerardo Ruiz-Ares
,
Laura Otero-Ortega
, Fernando Laso-García,
MaríCarmen Gómez-de Frutos
and
Exuperio Díez-Tejedor
Hospital Universitario La Paz - Department of Neurology and Stroke Center, Hospital Universitario La Paz - Department of Neurology and Stroke Center, Hospital Universitario La Paz - Department of Neurology and Stroke Center, Hospital Universitario La Paz - Department of Neurology and Stroke Center, Hospital Universitario La Paz - Clinical Trials Unit, Hospital Universitario La Paz - Clinical Trials Unit, Hospital Universitario La Paz - Department of Neurology and Stroke Center, Hospital Universitario La Paz - Department of Neurology and Stroke Center, Hospital Universitario La Paz - Department of Neurology and Stroke Center, Hospital Universitario La Paz - Department of Neurology and Stroke Center and Hospital Universitario La Paz - Department of Neurology and Stroke Center
Downloads
182
(418,025)
Citation
3
View PDF
Download
Abstract:
Stroke; Ischemic Stroke; Stem Cell; Randomised Clinical Trial; Safety
Feedback